Joachim Hasenmaier elected to BI's board of managing directors
This article was originally published in Scrip
Executive Summary
Boehringer Ingelheim has appointed Dr Joachim Hasenmaier to its board of managing directors. As of 1 October, Dr Hasenmaier will take responsibility for the new consumer health care and animal health board division. Prior to his appointment Dr Hasenmaier was regional business manager for Northern Europe and Canada